More on TRVI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Trevi Therapeutics (NQ:TRVI)
Delayed: 11.88 -0.23 (1.9%)
Prev. Close $12.11  
Open$12.08 
52 Wk High$ 
52 Wk Low$ 
Day High$12.08 
Day Low$11.70 
P/E N/A  
EPS$ 
Volume2,719,146 

Friends, Peers and Foes (?): AA, KNX, NFLX NI (more...)

Oct 13, 2026 07:30 AM Trevi Therapeutics Announces Oral Presentation Accepted at the CHEST 2026 Annual Meeting
Oct 8, 2026 09:53 AM Top 4 Healthcare Stocks Backed by Raymond James Analysts
Oct 7, 2026 09:36 AM BMO Capital: 'Trevi Therapeutics (TRVI) Stands Alone in RCC Following Nocion Study Failure'
Sep 25, 2026 06:03 AM Oppenheimer Reiterates Outperform Rating on Trevi Therapeutics (TRVI)
Sep 17, 2026 04:55 PM Form 4 Trevi Therapeutics, Inc. For: Sep 15 Filed by: Heffernan Michael Thomas
Sep 15, 2026 04:42 PM Form 144 Trevi Therapeutics, Inc. Filed by: Heffernan Michael Thomas
Aug 26, 2026 07:30 AM Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026
Aug 13, 2026 03:22 PM Trevi Therapeutics (TRVI) PT Raised to $28 at Jones Trading
Aug 7, 2026 11:00 AM Trevi Therapeutics (TRVI) PT Raised to $30 at Cantor Fitzgerald
Aug 7, 2026 08:05 AM Trevi Therapeutics (TRVI) PT Raised to $25 at Oppenheimer
View All Articles

Entities mentioned with TRVI

View All Entities